Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Tango Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 120 | 2 | 121 | +3 |
| Shares | 98.6M | 4.05M | 101.5M | +6.90M (+7.3%) |
| Value | $846.0M | $34.8M | $781.2M | −$30.1M (−3.7%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Tango Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,361,335 | $33.6M | 0.00% |
| Siren, L.L.C. | 2,603,897 | $20.1M | 1.00% |
| Integral Health Asset Management, LLC | 200,000 | $1.54M | 0.18% |
| Walleye Capital LLC | 142,576 | $1.10M | 0.01% |
| Marshall Wace, LLP | 73,122 | $563.0K | 0.00% |
| Tudor Investment Corp Et Al | 63,296 | $487.4K | 0.01% |
| Sphera Funds Management Ltd. | 50,000 | $385.0K | 0.06% |
| Gsa Capital Partners LLP | 45,272 | $349.0K | 0.03% |
| Verition Fund Management LLC | 32,020 | $246.6K | 0.00% |
| Intech Investment Management LLC | 30,910 | $238.0K | 0.00% |
| Brevan Howard Capital Management LP | 21,185 | $163.1K | 0.01% |
| SG Americas Securities, LLC | 19,644 | $151.0K | 0.00% |
| Nebula Research & Development LLC | 10,901 | $83.9K | 0.01% |
| Teacher Retirement System of Texas | 10,713 | $82.0K | 0.00% |
| TFC Financial Management | 300 | $2.31K | 0.00% |
| Simplex Trading, LLC | 287 | $2.00K | 0.00% |
| Sterling Capital Management LLC | 49 | $377 | 0.00% |
| Versant Capital Management, Inc | 28 | $216 | 0.00% |
Sold out (15)
Institutions that held Tango Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 2,519,841 | $21.6M |
| Point72 Asset Management, L.P. | 447,107 | $3.84M |
| Woodline Partners LP | 348,091 | $2.99M |
| Affinity Asset Advisors, LLC | 150,274 | $1.29M |
| Voloridge Investment Management, LLC | 38,201 | $327.8K |
| Fishman Jay A Ltd | 19,000 | $163.0K |
| Millennium Management LLC | 14,911 | $127.9K |
| Squarepoint Ops LLC | 14,158 | $121.5K |
| LMR Partners LLP | 14,000 | $120.1K |
| Principal Financial Group Inc | 10,497 | $90.1K |
| Alaethes Wealth LLC | 10,000 | $85.8K |
| Castleview Partners, LLC | 6,944 | $59.6K |
| Point72 (DIFC) Ltd | 6,281 | $53.9K |
| Catalyst Funds Management Pty Ltd | 1,400 | $12.0K |
| Pacer Advisors, Inc. | 415 | $3.56K |
Not filed for Q3 2024 yet (2)
Institutions that held Tango Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,987,852 | $34.2M |
| Susquehanna Fundamental Investments, LLC | 62,417 | $535.5K |